Status:
COMPLETED
Coronary Drug Project
Lead Sponsor:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Cardiovascular Diseases
Coronary Disease
Eligibility:
MALE
30-64 years
Phase:
PHASE3
Brief Summary
To determine whether regular administration of lipid modifying drugs (clofibrate, nicotinic acid, estrogen, dextrothyroxine) to men with a documented myocardial infarction would result in significant ...
Detailed Description
BACKGROUND: Correlation of high levels of serum cholesterol with an increased incidence and prevalence of coronary heart disease (CHD) was demonstrated--prior to the inception of the Coronary Drug Pr...
Eligibility Criteria
Men, ages 30-64. Three months beyond most recent myocardial infarction.
Key Trial Info
Start Date :
April 1 1965
Trial Type :
INTERVENTIONAL
End Date :
March 1 1985
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00000482
Start Date
April 1 1965
End Date
March 1 1985
Last Update
November 26 2013
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.